Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Asia Pacific & Middle East

Euro Genetics-2023

About Conference

We warmly invite all the participants across the globe to attend the "14th International Conference on Genetics and Genetic Disorders" dated March 27-28, 2023 in Paris, France. It assimilates keynote presentations, oral talks, poster displays, the Young Research Forum, E-Poster presentations, and exhibitions. Human genetics will offer an idea to the participants about the innovative strategies and convictions in the medical and research ideologies of genetic engineering and medical genetics put forward by the leading genetic professionals.

Featuring exhibits from editors of prestigious peer-reviewed journals, well-known active investigators and decision-makers in the fields of genetics and genetic disorders. Human Genetics is an exquisite event designed for international medical health professionals like scientists, researchers, professors, scholars, and other associated members of genetics to facilitate the application of research findings associated with human genetics and genetic disorders. The conference invites affiliates from all leading universities, research organizations, and related societies to present their research and share their experiences on all aspects of the rapidly expanding field, showcasing their most recent techniques. Genetics-2022 provides 2 days of study discussions on ways and methods associated with medicine and genetic technology.

Target audience

• Scientists

• Professors

• Research Scholars and students

• Manufacturing Medical device Companies Companies

• Geneology Associations

• Clinical genomics

• Research Professors

• Diagnosis and Treatment

• Junior/Senior research fellows of Genetics

• Genetic counseling

• Gene therapy

• Genomics

• Pharmacologists

• Genetic epidemiologists

• Geneticists

• NGO’s and Health Clubs

Why to attend?

Genetics-2023 aspires to bring together scientific researchers, students, business delegates, scientists, and health care organisations from around the world to contribute to the global conference by revealing the current intention, real-time developmental experiments, and groundwork effects. We expect that this educational circumstance will restore the persisting bond across the globe.

A gathering with professionals from around the world relating to human genetics and genetic disorders is your best opportunity to organise a huge gathering of participants from the scientific community.

This would be the right platform for scientists and maestros in human genetics and genetic disorders to exhibit their current research developments and ascertain their magisterial progress in genetics. This congress gives everyone a unique perspective and will leave an indelible impression in just a few days.

Sessions and Tracks

Track 1: Deoxyribonucleic acid

DNA is the information molecule. It stores instructions for making other large molecules, called proteins. These instructions are stored inside each of your cells, distributed among 46 long structures called chromosomes. These chromosomes are made up of thousands of shorter segments of DNA, called genes. The molecule inside cells that contains the genetic information responsible for the development and function of an organism. DNA molecules allow this information to be passed from one generation to the next.

  • Double stranded DNA
  • Thymine and Guanine bases
  • Uracil and Cytosine bases

Track 2: Chromosomes

In the nucleus of each cell, the DNA molecule is packaged into thread-like structures called chromosomes. Each chromosome is made up of DNA tightly coiled many times around proteins called histones that support its structure. Chromosomes are not visible in the cell’s nucleus—not even under a microscope—when the cell is not dividing. However, the DNA that makes up chromosomes becomes more tightly packed during cell division and is then visible under a microscope.

  • Centromere
  • Chromatids
  • Chromosome

Track 3:  Genetics

Genetics is the scientific study of genes and heredity—of how certain qualities or traits are passed from parents to offspring as a result of changes in DNA sequence. A gene is a segment of DNA that contains instructions for building one or more molecules that help the body work. DNA is shaped like a corkscrew-twisted ladder, called a double helix. The two ladder rails are called backbones, and the rungs are pairs of four building blocks (adenine, thymine, guanine, and cytosine) called bases. The sequences of these bases provide the instructions for building molecules, most of which are proteins. Researchers estimate that humans have about 20,000 genes. All of an organism’s genetic material, including its genes and other elements that control the activity of those genes, is its genome. An organism’s entire genome is found in nearly all of its cells. In human, plant, and animal cells, the genome is housed in a structure called the nucleus. The human genome is mostly the same in all people with just small variations. For more on the human genome, visit the National Human Genome Research Institute’s About Genomics webpage.

• Chromosome and Genes

• DNA linkages

• DNA Sequencing

• Offspring Characteristics

Track 4:  Genetic Disorders

Genetic disorders occur when a mutation (a harmful change to a gene, also known as a pathogenic variant) affects your genes or when you have the wrong amount of genetic material. Genes are made of DNA, which contain instructions for cell functioning and the characteristics that make you unique.

  • Cystic Fibrosis
  • Thalassemia
  • Sickle Cell Anemia
  • Huntington's Disease
  • Duchenne's Muscular Dystrophy
  • Tay-Sachs Disease

Track 5:  Biomarkers

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Biomarkers may be used alone or in combination to assess the health or disease state of an individual. A wide range of biomarkers are used today. Every biological system  has its own specific biomarkers. Many of these biomarkers are relatively easy to measure and form part of routine medical examinations.

  • Proteins.
  • Gene mutations
  • Gene rearrangements.
  • Extra copies of genes.
  • Missing genes.
  • Other molecules.

Track 6:  Pediatric Geneticist

All children with serious disorders will benefit from genetic analysis. Virtually every disease is the result of genetic and environmental interactions—and we learn a great deal about the course and treatment of an illness once the relevant genes are identified.

Clinical genetics at Columbia Doctors is comprised of highly trained and world-renowned physicians and researchers who are committed to the proper diagnosis and treatment of children and families with complex genetic problems and birth defects. Our pediatric geneticists and inherited disease experts have produced many new insights in this field, as we treat children with disorders that have a genetic cause, including Down syndrome, Turner syndrome, early onset cystic fibrosis, sickle cell disease, and amino acid disorders.

  • Birth defects
  • Down syndrome
  • Williams syndrome

Track 7:  Human Genetics

It is the study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that in other organisms.The study of human heredity occupies a central position in genetics. Much of this interest stems from a basic desire to know who humans are and why they are as they are. At a more practical level, an understanding of human heredity is of critical importance in the prediction, diagnosis, and treatment of diseases that have a genetic component. The quest to determine the genetic basis of human health has given rise to the field of medical genetics. In general, medicine has given focus and purpose to human genetics, so the terms medical genetics and human genetics are often considered synonymous.

  • Familial Alzheimer's Disease.
  • Familial FTD.
  • Familial Prion Disease.
  • Genetic Counseling.

Track 8:  Plant Genetics

It utilizes plants to make substantial amounts of pharmaceutical substances like antibodies and vaccines. it's as same because the technique for creating Genetically Modified Crops, the synthetic introduction of genes into plants. Plant Genetics is that the study of genes, hereditary variety, and genetics, particularly in Plants. It is, for the foremost part, considered a field of biology and botany; however, it crosses much of the time with numerous other life sciences and is firmly connected with the investigation of knowledge frameworks. In agriculture, a plant's qualities impact the development of the plant, as they're parts of its chromosomes and are acquired through sexual propagation. There are two alternative ways by which qualities are often changed: the gene gun method strategy and therefore the agrobacterium technique. The gene gun method technique is especially helpful in changing monocot species like corn and rice and is otherwise called biolistic. The agrobacterium strategy has been effectively drilled in dicots, i.e. broadleaf plants, for instance, soybeans and tomatoes, for an extended time. It’s likewise viable in monocots like grasses, including corn and rice.

  • Molecular breeding
  • Marketing and societal issues in breeding
  • Plant cellular organization and genetic structure
  • Plant genetic resources

Track 9:  Animal Genetics

Animal breeding is a branch of animal science that addresses the evaluation of genetic value in terms of estimated breeding value (EBV) of domestic livestock. Animals have been selected for breeding with superior EBVs in growth rate, and egg, meat, milk, or wool production, as well as other important desirable traits. Breeding animals begins with a decision to continue with a current population of animals or to replace part or all of it with new breeds or lines. Region, country, climate, management, prevalent diseases and parasites, product types, import restrictions, and history influence popularity and choice of breeds and lines. For some species and places, livestock producers used the same breeds over long periods, but in other species and places they often changed the breeds. The predominant breed for dairy cattle production is Holstein in many countries with temperate climates. Commercial egg production depends on selected lines developed from Leghorn chickens. Beef cattle, swine, and sheep producers use many breeds to adapt to regional and marketing differences.

Track 10:  Genome Integrity

Genome instability is mainly due to sporadic replication or repair errors but can also take place in response to developmental or environmental signals, as occurs in meiosis, and antigen receptor and immunoglobulin gene diversification in T and B cells. Genomes are transmitted faithfully from dividing cells to their offspring. Changes that occur during DNA repair, chromosome duplication, and transmission or via recombination provide a natural source of genetic variation. They occur at low frequency because of the intrinsic variable nature of genomes, which we refer to as genome instability. However, genome instability can be enhanced by exposure to external genotoxic agents or as the result of cellular pathologies.

Track 11:  Epigenetics & Chromatin

Epigenetics is the study of the configuration and chemistry of DNA in chromosomes and changes in gene expression patterns that cannot be traced to the DNA sequence. Unlike phenotypes that are associated with mutations in the underlying DNA code, epigenetic changes involve heritable covalent modifications to chromatin structure, such as DNA methylation and histone modification. Here we highlight common epigenetic markers, the techniques used to study them, and their role in biology and human disease. DNA is stored in a highly structured complex called chromatin. Epigenetic processes control gene expression by altering chromatin structure (Figure 1). Actively transcribed genes are associated with accessible chromatin regions, while transcriptionally silent genes are found in inaccessible chromatin regions. These modifications made to DNA and proteins, which impact chromatin structure, are referred to as epigenetic markers (or marks) and subsequently inherited as they are passed on through rounds of cell division.

  • DNA Methylation. DNA methylation works by adding a chemical group to DNA
  • Histone modification. DNA wraps around proteins called histones
  • Non-coding RNA. Your DNA is used as instructions for making coding and non-coding RNA.

Track 12:  Molecular and Cellular Genetics

It is a sub-field of biology that addresses how differences in the structures or expression of DNA molecules manifests as variation among organisms. Molecular genetics often applies an "investigative approach" to determine the structure and/or function of genes in an organism's genome using genetic screens. The field of study is based on the merging of several sub-fields in biology: classical Mendelian inheritance, cellular biology, molecular biology, biochemistry, and biotechnology. Researchers search for mutations in a gene or induce mutations in a gene to link a gene sequence to a specific phenotype. Molecular genetics is a powerful methodology for linking mutations to genetic conditions that may aid the search for treatments/cures for various genetics diseases.

Track 13:  Cytogenetics

Cytogenetic  is the study of cell structure, area, and ability of chromosomes. It involves studying the number and presence of chromosomes (karyotyping), the physical region of chromosomal properties, and chromosomal actions in procedures such as cell division. The ordinary human cell consists of 46 chromosomes: 22 autosomal pairs, numbered 1-22 by decreasing length query, 1 array of gonosomes, or sex chromosomes.

  • Chromosomes
  • Human mouse somatic cell hybrids
  • Chromosome abnormalities
  • Tumour Cytogenetics

Track 14: Bioinformatics

Bioinformatics is a field of computational science that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein, and is particularly useful in comparing genes and other sequences in proteins and other sequences within an organism or between organisms, looking at evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is. You can think about bioinformatics as essentially the linguistics part of genetics. That is, the linguistics people are looking at patterns in language, and that's what bioinformatics people do--looking for patterns within sequences of DNA or protein.

  • Creation of databases
  • Development of algorithms and statistics
  • Analysis of data and interpretation

Track 15: Reproductive Genetics/Prenatal Genetics

Immature microorganisms are undifferentiated regular cells that experience mitosis to convey more cells, which are found in multicellular living things. They are of two sorts, embryonic and grown up microorganisms. The undeveloped cell treatment was seen to be a lifesaving treatment for the patients with solid tumours and blood issue. Essential microorganisms are often obtained from the umbilical string after new-born’s first experience with the planet. Maybe they can moreover be gotten from periphery blood and bone marrow. As demonstrated by the reports, in US the availability of undifferentiated cell treatment was $15.2 million of each 2007 and $16.5 million of each 2008 and it is surveyed to reach $11 billion by 2020.

Undifferentiated creature treatment is the strategy for using undeveloped cells for with respect to and furthermore keeping any disease or strife. Bone marrow transplantation is the most by and large used youthful microorganism treatment, anyway some undeveloped cell treatment using umbilical string bloods are similarly for all intents and purposes.

  • Somatic Cell Reprogramming
  • Tissue Regeneration
  • Vascular Regeneration
  • Articular Cartilage Tissue 211 Engineering
  • Oral Bone Reconstruction

Track 16: Neutrigenetics

Precision Nutrition is a relatively new term that can be considered as a way to use information we continue to learn about our genomics in order to customise nutritional advice. Progress in scientific and medical research has led to understanding our biology as a whole system, known as the -omics era. The knowledge we can apply from -omics technology, together with understanding of nutrient-gene interactions has developed a field known as Nutritional Genomics.

At present, the nutritional genomic relationship is made up of two related but distinct fields namely, Nutrigenomics and Nutrigenetics. Nutrigenomics focuses on how diet affects gene expression. Nutrigenetics focuses on how the gene variants in our DNA influences our response to nutients i.e. how our genes determine the effects what our food has on us.  Both aim to elucidate how the genome interacts with nutrition to influence genotype to optimise health through the application of personalised and precision nutrition.

Track 17: Forensic Genetics

Forensic genetics  in the department of genetics that deals with the software of genetic know-how to criminal issues and felony proceedings. Forensic genetics is also a branch of forensic medication that offers greater extensively with the software of medical knowledge to prison matters.

Forensic genetics today has a tendency to conjure up DNA. However, even the term "DNA fingerprinting" is like older methods of police identification. Forensic genetics isn't a new field. Long earlier than the technology of DNA fingerprinting, blood grouping, HLA typing and other assessments of genetic markers in blood were finished to try to determine who did it (and, greater often, who did no longer do it).

  • DNA Fingerprinting
  • Evaluation and presentation of DNA evidence
  • Kinship testing
  • Lineage markers

Track 18: Cancer Genetics

From the time Boveri observed that chromosomal changes are a feature of cancer, it has been thought to be a disease caused primarily by alterations in the genome of the affected cells. Today, the notion of cancer being a consequence of genetic alterations, is almost intuitive and the advances in molecular biology and genomics have given us many tools to understand and possibly to combat cancer. Since science has always existed in a continuum, the genetic alterations in cancer have to be understood in the context of cellular organization, differentiation, tissue organization host response and susceptibility angiogenesis etc. The properties that are taken to typify cancer cells are also present in normal cells. These include cell division, migration and even invasion. However what marks out cancer cells is dysregulation and inappropriate expression of these attributes. Typically the genetic alterations in cancer can be said to include three major types of genes, oncogenes, tumour suppressor genes and genes that preserve the integrity of the genome. It must be kept in mind that cancer is a multi-step process and several genetic alterations are required for a full blown cancer phenotype.

Track 19:  Neurogenetics

Neurogenetics studies the role of genetics in nervous system development and function. This recognizes neural features like phenotypes (i.e., observable or non-measurable manifestations of an individual's genetic make-up) and is mainly based on the fact. Individuals nervous systems are belonging to the same species, may not be the same. As the name implies, it draws elements from both neuroscience and genetics research, concentrating especially on how its transmitted characteristics influence the ordering that an organism bears. Mutations can have a good range of effects on the individual's quality of life during this genetic sequence. In the context of neurogenetics, neurological diseases, behaviour, and personality are all studied. In the mid to late 1900s, the field of neurogenetics emerged with developments and closely following advances made in the technologies available.

  • Behavioral neurogenetics
  • Cross-species gene conservation
  • Neural development
  • Cognitive genomics
  • Computational Neurogenetic Modeling

Track 20: Regulatory and Safety Aspects of Cell and Gene Therapy

Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use.

Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms:

  • Replacing a disease-causing gene with a healthy copy of the gene
  • Inactivating a disease-causing gene that is not functioning properly
  • Introducing a new or modified gene into the body to help treat a disease

Gene therapy products are being studied to treat diseases including cancer, genetic diseases, and infectious diseases.

There are a variety of types of gene therapy products, including:

  • Plasmid DNA: Circular DNA molecules can be genetically engineered to carry therapeutic genes into human cells.
  • Viral vectors: Viruses have a natural ability to deliver genetic material into cells, and therefore some gene therapy products are derived from viruses. Once viruses have been modified to remove their ability to cause infectious disease, these modified viruses can be used as vectors (vehicles) to carry therapeutic genes into human cells.
  • Bacterial vectors: Bacteria can be modified to prevent them from causing infectious disease and then used as vectors (vehicles) to carry therapeutic genes into human tissues.
  • Human gene editing technology: The goals of gene editing are to disrupt harmful genes or to repair mutated genes.
  • Patient-derived cellular gene therapy products: Cells are removed from the patient, genetically modified (often using a viral vector) and then returned to the patient.

Track 21: Molecular biology

The field of molecular biology studies macromolecules and the macromolecular mechanisms found in living things, such as the molecular nature of the gene and its mechanisms of gene replication, mutation, and expression. Given the fundamental importance of these macromolecular mechanisms throughout the history of molecular biology, a philosophical focus on the concept of a mechanism generates the clearest picture of molecular biology’s history, concepts, and case studies utilized by philosophers of science.

Track 22: Neuro genetics

Neuro genetic disorders are prominently seen in clinical genetics practice and have increased notably with the advent of molecular approaches. Next-generation DNA sequencing techniques have made it possible to examine a large number of possible disease genes in a single reaction, which was impossible to do with previous methods. This has resulted in the rapid identification of genes involved in Mendelian disorders, thereby making a precise diagnosis of many neurological disorders possible. Genetic testing for the same can be considered in the early stages of the diagnostic procedure.

Market Analysis

Euro Genetics Market is expected to reach $16.92 Billion by 2029 from $11.81 Billion in 2021 at a CAGR of 4.6 %. Euro Genetics is a field of medicine that deals with the Genetic Engineering & Gene Therapy-Sharing Discoveries of the Future Human Genome. Region/country wise Genetics market report is available at Euro Genetics 2023

Genetics market-Global industry analysis, size, share, growth, trends & forecast 2017-2026. Global genetic market is expecting a healthy growth at a CAGR of 11.5% during the forecast period of (2017-2026). It is to be noticed that the global genetic market has accounted for $7749.00 million in 2017 and is expected to reach &25948.46 million by 2026 growing at a CAGR of 14.37%during the forecast period. The Europe is one of the successful managements in Human genetics next to U.S. Europe has the significant rise in the Human genetics market. The estimation will reach the valuation of USD2253.10Mn by the end of 2023.

The most recent trends and developments in the global industry are outlined in the "Global Genetics Market" research report, which covers the period from 2017 to 2026. It also covers all of the important growth factors. It provides a comprehensive overview of the top manufacturers' business development plans, current industry status, growth segments, and scope for the future. The goal of the Genetic Market report is to provide regional development for the rate of growth of the market in the future as well as market driving factors, such as sales revenue. Using a variety of research methods, such as SWOT and PESTLE analysis, it provides in-depth research and analysis of key aspects and highlights the current market situation. In addition, the report provides insightful data on global players' upcoming strategies and opportunities.

Insights and Market Analysis on Global Genetic Market:

The process of altering genes in an organism or species with the intention of improving its capabilities is known as "genetic engineering." Pharmaceutical, biotechnology, and clinical research organizations all make use of the technology. Gene therapy is the most common method used in medicine to treat cancer and other infectious diseases.

By 2028, the global market for genetic engineering is expected to be worth USD 5998.3 million, up from USD 3053.5 million in 2021, with a CAGR of 10.0% between 2017 and 2026.

This market's expansion is likely to be primarily fueled by the widespread application of various technologies like CRISPR/Cas9, TALEN, and ZNF in gene therapy for various genetic disorders and life-threatening conditions.

The report makes an excellent effort to reveal the key opportunities that are available in the global genetic engineering market in order to assist players in establishing a solid position in the market with an analysis that complies with industry standards and high data integrity. The report provides access to verified and trustworthy market forecasts, such as those for the global genetic engineering market's overall revenue size.

In general, the report proves to be a useful tool for players looking to gain an advantage over their rivals and ensure long-term success in the global market for genetic engineering. The entirety of the discoveries, information, and data given in the report are approved and revalidated with the assistance of dependable sources. An in-depth examination of the global genetic engineering market was carried out by analysts employing a novel and industry-leading method of research and analysis.

The players, region (country), type, and application segments of the global genetic engineering market are reflected in the market's scope and size. Using the report as a powerful resource, players, stakeholders, and other participants in the global genetic engineering market will be able to gain an advantage. The revenue and forecasts for 2017–2026 by type and application are the primary focus of the segmental analysis.

Analysis of Genetics Market Share and the Competitive Landscape:

The competitive landscape of the genetic market provides information and details about players. The player's revenue for 2017–2026 is thoroughly examined and accurately analysed in this report. In addition, it provides in-depth analysis backed up by reliable statistics on players' revenue (at the global and regional levels) for 2017–2026. The company's description, major businesses, total revenue and sales, revenue from the genetic engineering business, the date of entry into the genetic engineering market, the introduction of genetic engineering products, recent developments, and other details are included.

Segmentation of the Global Market for Genetics into Types, Applications, and Regions:

The global market for genetic is examined, and information on the market's size by region (countries) is provided. The market for genetic engineering is divided into the United States, Europe, China, Japan, Southeast Asia, India, and the Rest of the World according to application. Market sizes by region are included in the report for the years 2017–2026. It also includes 2017–2026 sales and revenue forecasts by player, type, and application segment for the market's size.

A global genetic market zone survey:

The United States of America is the largest market in the world for the enormous growth of human genetics. The human genetics market in the United States is expected to grow at a CAGR of 9.9% over the forecast period to reach USD 19.99 billion in 2023.


In 2017, the European market was estimated to be worth $1.22 billion, and by 2021, it is expected to be worth $1.81 billion, over the course of the forecast period, expanding at a CAGR of 8.2%.

Pacific Asia:

By 2021, the market is expected to be worth USD 5.30 billion, up from USD 3.39 billion in 2017, representing a CAGR of 9.3%. During the forecast period, China's primary growth is anticipated to be 13.2%.

Near East:

In 2017, the global market for human genetics was estimated to be worth $419.4 million and was anticipated to expand at a rate of 13.9% over the next five years.


The research and development companies, genetics and genomics companies, medical research laboratories, academic medical institutes, and universities are the intended audiences for the expansion of the global human genetics market. The instrumentation, methods, applications, and end-user segments make up the global market for human genetics.

During the forecast period of 2017–2026, the global market for human genetics is anticipated to experience healthy growth at a CAGR of 11.5 percent. It is important to note that the global genetic market was worth $774.99 million in 2017 and is projected to grow to $25948.46 million by 2026, growing at a CAGR of 14.37 percent over the forecast period.

The following is a list of the major players in the genetic engineering market:

Fisher Scientific Thermo Fisher Scientific, The GenScript, Amgen, Genentech, MerckGroup Horizon Discovery, Therapeutics Sangamo, and Biopharmaceuticals Transposagen.

Conference Series is one of the world's most distinguished organizers of scientific conferences, displaying its individuality in all areas of science, technology and business. One element of the success of any conference series, in particular, depends on how far it reaches the online community. Having a web audience is crucial to making an international gathering a huge success, be it research, science, or industry. 

Research staff, academics, research institutes, industrialists, and students in the field of genetics are the main participants, showing an intense desire to attend the human genetics conference hosted by Conferences Series. The conference-supported formulations, pharmaceuticals, and genomics exhibit a significant number of unique visitors and page views that have proven to be a resounding success. Conference Series pushes its boundaries by tracking every conference that takes place on the respective conference web pages and its official social media accounts. So this means the participation of the international scientific and industrial communities to come and experience the package of conferences, discussions, product exhibitions, and alliances.

Zone survey of Global Genetic Market:


America is the largest market for its colossal growth of Human genetics. The U.S Human genetics market is assured to reach the USD 19.99 Billion in 2023, growing at a CAGR of 9.9%during the forecast period.


The Europe market is estimated at USD 1.22 billion in 2017, and is projected to reach USD 1.8 billion in 2021. Growing at the annual growth rate (CAGR) of 8.2% during the forecast period.

Asia pacific:

The market is energised to expect the USD 5.30 billion by 2021 from the USD 3.39 Billion in 2017 at a CAGR of 9.3%. The primary growth of China is expected to be at a growth rate of 13.2% in the forecast period.

Middle East:

The global Human genetics market is to be estimated $419.4 million in 2017 and is expected to grow at a rate of 13.9% in the next five years.    


The viewer’s meant for the growth of the global Human genetics market include, R&D companies, Genetics & Genomic companies, Medical research laboratories, Academics medical institutes and universities. The global Human genetics market is divided by Instruments, methods, applications, end-users.

Global Human genetics market is expecting a healthy growth at a CAGR of 11.5% during the forecast period of (2017-2026). It is to be noticed that the global genetic market has accounted for $7749.00 million in 2017 and is expected to reach &25948.46 million by 2026 growing at a CAGR of 14.37%during the forecast periods.

Key players:

Agilent technologies (U.S.)

Bode technologies (U.S.)

GE Healthcare(U.K.)


Orchid Cellmark,Inc(U.S.)

QIAGEN N.V(Netherland)

Past Conference Report


We warmly invite all the participants across the globe to attend the "EURO GENETIC DISORDERS 2022" dated June 22-23, 2022 London, UK. It assimilates keynote presentations, oral talks, poster displays, the Young Research Forum, E-Poster presentations, and exhibitions. Human genetics will offer an idea to the participants about the innovative strategies and convictions in the medical and research ideologies of genetic engineering and medical genetics put forward by the leading genetic professionals.

Featuring exhibits from editors of prestigious peer-reviewed journals, well-known active investigators and decision-makers in the fields of genetics and genetic disorders. Human Genetics is an exquisite event designed for international medical health professionals like scientists, researchers, professors, scholars, and other associated members of genetics to facilitate the application of research findings associated with human genetics and genetic disorders. The conference invites affiliates from all leading universities, research organizations, and related societies to present their research and share their experiences on all aspects of the rapidly expanding field, showcasing their most recent techniques.

Genetics-2022 provides 2 days of study discussions on ways and methods associated with medicine and genetic technology. Target audience • Scientists • Professors • Research Scholars and students • Manufacturing Medical device Companies Companies • Geneology Associations • Clinical genomics • Research Professors • Diagnosis and Treatment • Junior/Senior research fellows of Genetics • Genetic counseling • Gene therapy • Genomics • Pharmacologists • Genetic epidemiologists • Geneticists • NGO’s and Health Clubs

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 27-28, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Human Genetics & Embryology Molecular and Genetic Medicine

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


  • ?Gene And Cell Therapy For Rare & Common Diseases
  • ?Viral Gene Therapy
  • Advanced Gene Therapeutics
  • Advances In Biomedical Engineering, Imaging And Screening
  • Bioengineering Therapeutics
  • Biomarkers
  • Cancer Cells & Biomarkers
  • Cell & Gene Therapy
  • Cell & Gene Therapy Development & Production
  • Cell And Gene Therapy For Rare & Common Diseases
  • Cell Biology
  • Cell Culture And Bioprocessing
  • Cell Damage And Adaptation
  • Cell Science And Stem Cell Research
  • Cell Science Research
  • Cell Therapy
  • Cell Therapy Bioprocessing
  • Cell Therapy For Cardiovascular And Neurological Disorders
  • Cell Therapy Of Cardiovascular Disorders
  • Cellular And Technological Breakthroughs In Cancer
  • Clinical And Translational Research
  • Clinical Trials On Cell & Gene Therapy
  • Commercialization
  • Epigenetics
  • Ethical Issues In Cell And Gene Therapy
  • Gene Editing And CRISPR Based Technologies
  • Gene Therapy
  • Gene Therapy For Diseases
  • Genetic Engineering
  • Genetic Medicine
  • Genetics & Genomic Medicine
  • Genome Editing
  • Genomics
  • Immunotherapy
  • Market And Future Prospects Of Gene Therapy
  • Markets & Future Prospects For Cell & Gene Therapy
  • Molecular Basis Of Epigenetics
  • Molecular Medicine
  • Nano Therapy
  • Nanotechnology In Stem Cells
  • Nanotherapy
  • Nuclear Medicine
  • Nucleotide-based Vaccines
  • Proteomics
  • Rare Diseases & Orphan Drugs
  • Regenerative Medicine
  • Regulatory And Safety Aspects Of Cell And Gene Therapy
  • Stem Cell In Gene Therapy
  • Stem Cell Research
  • Stem Cell Research And Regenerative Medicine
  • Stem Cell Therapies
  • Stem Cell Therapy
  • Synthetic Biology And CRISPR Technology
  • Technologies In Stem Cell Research
  • Tissue Engineering & Biomaterials
  • Tissue Engineering & Regenerative Medicine
  • Tissue Science & Regenerative Medicine
  • Tissue Science And Regenerative Medicine
  • Viral Gene Therapy